Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 4Phase 3 3Phase 1/2 2

Status

Completed 4Withdrawn 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 3Other solid neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Solid Tumors 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1

Interventions

Paclitaxel 292Gemcitabine 254Carboplatin 254Cisplatin 251Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 181Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Pemetrexed 90Ipilimumab 90fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Completed × glasdegib × Clear all
NCT02038777 2025-02-26

A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies

Pfizer

Phase 1 Completed
48 enrolled 85 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT00953758 2024-04-25

A Study Of PF-04449913 In Select Hematologic Malignancies

Pfizer

Phase 1 Completed
47 enrolled 45 charts
Other hematologic neoplasm

Hematologic Neoplasms

NCT01286467 2024-03-06

A Study Of PF-04449913 Administered Alone In Select Solid Tumors

Pfizer

Phase 1 Completed
23 enrolled 26 charts
Other solid neoplasm

Solid Tumors

NCT02367456 2024-01-19

BRIGHT 1012

Pfizer

Phase 1 Completed
73 enrolled 31 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡